Growing community of inventors

Dublin, CA, United States of America

Andrew King

Average Co-Inventor Count = 4.55

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 7

Andrew KingPhilip Thomas Frohlich (4 patents)Andrew KingChidambaram Ramachandran (4 patents)Andrew KingSarah Beth Noonberg (4 patents)Andrew KingMichael Robert Leadbetter (1 patent)Andrew KingJeffrey William Jacobs (1 patent)Andrew KingDean R Dragoli (1 patent)Andrew KingJason Gustaf Lewis (1 patent)Andrew KingChristopher Carreras (1 patent)Andrew KingNoah Bell (1 patent)Andrew KingMatthew John Siegel (1 patent)Andrew KingIrina Dotsenko (1 patent)Andrew KingYing He (1 patent)Andrew KingRoger Elmer (1 patent)Andrew KingScott Troutman (1 patent)Andrew KingBrett Jackson (1 patent)Andrew KingAndrew King (5 patents)Philip Thomas FrohlichPhilip Thomas Frohlich (4 patents)Chidambaram RamachandranChidambaram Ramachandran (4 patents)Sarah Beth NoonbergSarah Beth Noonberg (4 patents)Michael Robert LeadbetterMichael Robert Leadbetter (66 patents)Jeffrey William JacobsJeffrey William Jacobs (43 patents)Dean R DragoliDean R Dragoli (33 patents)Jason Gustaf LewisJason Gustaf Lewis (29 patents)Christopher CarrerasChristopher Carreras (27 patents)Noah BellNoah Bell (20 patents)Matthew John SiegelMatthew John Siegel (11 patents)Irina DotsenkoIrina Dotsenko (7 patents)Ying HeYing He (1 patent)Roger ElmerRoger Elmer (2 patents)Scott TroutmanScott Troutman (2 patents)Brett JacksonBrett Jackson (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Chinook Therapeutics, Inc. (4 from 8 patents)

2. Ardelyx, Inc. (1 from 39 patents)


5 patents:

1. 12370174 - Methods of improving renal function

2. 12121509 - Methods of improving renal function

3. 11998526 - Methods of improving renal function

4. 11491137 - Methods of improving renal function

5. 10376481 - Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…